Fallopian tube correlates of ovarian serous borderline tumors
- PMID: 22089527
- PMCID: PMC3219906
- DOI: 10.1097/PAS.0b013e318233b0f7
Fallopian tube correlates of ovarian serous borderline tumors
Abstract
Ovarian serous borderline tumors (SBTs) are presumed to originate in the ovarian cortex or peritoneal surface. The pathogenetic role of the fallopian tube (FT) is unclear; however, recently, secretory cell outgrowths (SCOUTs) lacking PAX2 expression were described in benign FTs. This study addressed (1) the differentiation characteristics of SBTs and (2) the frequency of SCOUTs lacking PAX2 expression in the FTs of patients with SBTs and compared (3) SCOUT morphology and (4) PAX2 expression with SBTs. SBTs and FT epithelium shared both ciliated (p73) and secretory (HMFG2) differentiation. PAX2-null SCOUT frequency in FT cross-sections from patients with SBTs was 0.28 (110 of 398) versus 0.112 in benign hysterectomies and nearly 0 in pediatric and postpartum sterilization specimens (P = < 0.001). When adjusted for age, the differences narrowed but remained significant (P = 0.010). SCOUTs were heterogeneous, some displaying ciliated differentiation and papillary architecture. Two cases of discrete multifocal papillary SCOUTs in the FTs were associated with SBTs. All SBTs had heterogeneous PAX2 staining with areas of PAX2 loss. This study shows for the first time that PAX2-null SCOUTs are more common in the oviducts of women with SBTs and that loss of PAX2 expression occurs in most SBTs. These discoveries link both morphologic and functional gene (PAX2) alterations in the oviduct to SBTs, similar to that reported in high-grade serous carcinoma. Further study is warranted to clarify the relationship of the oviduct to serous neoplasia.
Figures
Similar articles
-
PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer.Mod Pathol. 2012 Mar;25(3):449-55. doi: 10.1038/modpathol.2011.175. Epub 2011 Nov 11. Mod Pathol. 2012. PMID: 22080059
-
[Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].Zhonghua Fu Chan Ke Za Zhi. 2017 Oct 25;52(10):687-696. doi: 10.3760/cma.j.issn.0529-567X.2017.10.008. Zhonghua Fu Chan Ke Za Zhi. 2017. PMID: 29060967 Chinese.
-
Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube.J Pathol. 2010 Sep;222(1):110-6. doi: 10.1002/path.2739. J Pathol. 2010. PMID: 20597068 Free PMC article.
-
STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis.Front Biosci (Elite Ed). 2011 Jan 1;3(2):625-34. doi: 10.2741/e275. Front Biosci (Elite Ed). 2011. PMID: 21196340 Review.
-
[Fallopian tube: the dark face of pelvic carcinogenesis].Ann Pathol. 2011 Oct;31(5):345-52. doi: 10.1016/j.annpat.2011.06.008. Epub 2011 Sep 25. Ann Pathol. 2011. PMID: 21982240 Review. French.
Cited by
-
Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.Am J Surg Pathol. 2011 Nov;35(11):1605-14. doi: 10.1097/PAS.0b013e318229449f. Am J Surg Pathol. 2011. PMID: 21997682 Free PMC article.
-
Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms.Front Oncol. 2013 Aug 26;3:217. doi: 10.3389/fonc.2013.00217. eCollection 2013. Front Oncol. 2013. PMID: 23986883 Free PMC article.
-
Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.JCI Insight. 2016 Jul 7;1(10):e86829. doi: 10.1172/jci.insight.86829. JCI Insight. 2016. PMID: 27482544 Free PMC article.
-
Incidence of serous tubal intraepithelial carcinoma (STIC) by algorithm classification in serous ovarian tumor associated with PAX8 expression in tubal epithelia: a study of single institution in Japan.Int J Gynecol Pathol. 2015 Jan;34(1):9-18. doi: 10.1097/PGP.0000000000000108. Int J Gynecol Pathol. 2015. PMID: 25473747 Free PMC article.
-
Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.Am J Surg Pathol. 2015 Nov;39(11):1548-57. doi: 10.1097/PAS.0000000000000476. Am J Surg Pathol. 2015. PMID: 26099008 Free PMC article.
References
-
- Auersperg N. The origin of ovarian carcinomas: a unifying hypothesis. Int J Gynecol Pathol. 2011;30:12–21. - PubMed
-
- Colgan TJ, Murphy J, Cole DE, et al. Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status. Am J Surg Pathol. 2001;25:1283–1289. - PubMed
-
- Comer MT, Leese HJ, Southgate J. Induction of a differentiated ciliated cell phenotype in primary cultures of Fallopian tube epithelium. Hum Reprod. 1998 Nov;13(11):3114–20. - PubMed
-
- Feeley KM, Wells M. Precursor lesions of ovarian epithelial malignancy. Histopathology. 2001 Feb;38(2):87–95. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical